Boehringer Ingelheim
Manufacturing · Connecticut, United States · 1,000 Employees
View Company Info for Free
About
Headquarters
Ridgefield, Connecticut, 06877, United StatesPhone Number
(800) 243-0127Revenue
$271.6 MillionIndustry
Most Recent Scoops
Who is Boehringer Ingelheim
Boehringer Ingelheim USA Corporation is a leading pharmaceutical company dedicated to improving human and animal health through innovative research and development. With a strong presence in the United States, Boehringer Ingelheim USA focuses on delivering cutting-edge medicines and healthcare solutions that address a wide range of medical needs.Read more
Popular SearchesBoehringer Ingelheim USA CorpBoehringer Ingelheim USABoehringer Ingelheim Pharma GmbH & Co KGBoehringer Ingelheim Veterinary Scholars Programboehringer ingelheim us CorpSIC Code 28,283NAICS Code 32,325Show moreBoehringer Ingelheim Org Chart
Is Boehringer Ingelheim your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Boehringer Ingelheim recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Boehringer Ingelheim is spiking on competitors!
Check if Boehringer Ingelheim has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Boehringer Ingelheim
Click to see if Boehringer Ingelheim had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Boehringer Ingelheim has new funding data
Website visits: Recent activity has been detected on your website
Boehringer Ingelheim, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Boehringer Ingelheim launches new products
Recommended Actions
Find VP level buyers at Boehringer Ingelheim
Find 2 more new buyers
Boehringer Ingelheim Email Formats
Boehringer Ingelheim uses at least 5 email formats with first.last (ex. John.Smith@boehringer-ingelheim.com) being used 92.1% of the time
Boehringer Ingelheim Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@boehringer-ingelheim.com | 92.1% |
first + last | JohnSmith@boehringer-ingelheim.com | |
first_last | John_Smith@boehringer-ingelheim.com | |
first | John@boehringer-ingelheim.com | |
last | Smith@boehringer-ingelheim.com |
Get Verified Emails
Boehringer Ingelheim Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Boehringer Ingelheim Tech Stack
Most Recent Scoops
Boehringer Ingelheim News & Media
Boehringer Ingelheim CARES Foundation Ignites a Brighter Future in Vet Med with a $500,000 Scholarship Pledge to Tuskegee University College of Veterinary Medicine
DULUTH, Ga., June 12, 2024 /PRNewswire/ -- The Boehringer Ingelheim CARES Foundation, an independent nonprofit organization, is lighting the path to a more diverse future in veterinary medicine with a pledge of $500,000 in scholarship funds to the Tuskegee University College of Veterinary...Delaware judge lets more than 70,000 Zantac lawsuits go forward
The ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a setback for former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim, which had argued that the expert witnesses' opinions lacked scientific support. “This moves us one step closer to justice for our clients,” Brent Wisner, one of the plaintiffs' lead lawyers, said in a statement on Saturday.New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
RIDGEFIELD, CT, May 16, 2024 - (ACN Newswire) - XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. This research team's main objective is to develop complex, physiologically relevant disease models that deepen our understanding of dysfunctional wound healing and fibrosis. The end goal is to study fibrosis, drug delivery strategies, and drug safety in parallel, in anBoehringer Ingelheim expands access to Humira biosimilar
Boehringer Ingelheim will manufacture adalimumab-adbm for Quallent Pharmaceuticals.
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Boehringer Ingelheim
Boehringer Ingelheim USA Corporation is a leading pharmaceutical company dedicated to improving human and animal health through innovative research and development. With a strong presence in the United States, Boehringer Ingelheim USA focuses on delivering cutting-edge medicines and healthcare solutions that address a wide range of medical needs.... Read More